You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥(02196.HK)擬參與設立創新基金 投資醫療器械、醫療科技及相關產業的初創期創新型、早中期創新型企業
格隆匯 01-07 21:20

格隆匯1月7日丨復星醫藥(02196.HK)公吿,於2022年1月7日,公司附屬公司大連復健、寧波復瀛,公司控股股東復星高科技、大連融達及旅順國投訂立目標基金合夥協議,內容有關(其中包括)設立目標基金,其計劃募集資金為人民幣5億元。"目標基金"指根據目標基金合夥協議擬設立的大連星未來創業創新基金合夥企業。

目標基金將主要參股投資醫療器械、醫療科技及相關產業的初創期創新型、早中期創新型企業。

根據目標基金合夥協議,復健基金將獲委託作為目標基金的基金管理人,據此,目標基金、大連復建及復健基金將就目標基金的相關基金管理事宜訂立目標基金管理協議,為期3年。

復健基金是一家於中國成立的有限責任公司,為本公司的附屬公司,其主要從事大健康醫療產業創新領域的股權投資管理,並在中國證券投資基金業協會登記為私募基金管理人,登記編碼為P1070608。

於公吿日期,復健基金分別由公司及復星高科技持有60%及40%股權。復星高科技為本公司控股股東,且為復星國際有限公司(一家於香港聯交所主板上市的公司,股份代號:00656)的全資附屬公司。

本次通過對目標基金的投資,旨在挖掘醫療器械、醫療科技及相關領域優質的初創型、早中期的創新型企業標的,獲取投資回報,並拓寬與創新產品和技術的合作渠道、推動優質項目導入。於目標基金設立完成後,目標基金將納入本公司合併報表範圍。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account